Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Sorry u are a loser. I'm a winner nut case. In at $8.36. What is it at now?
Someone knows something!!!!
SOARING now. FEDs to announce rescheduling this week.
That 7 am PR bout to come. See y'all at $128
Enhanced lettuce out in PR today. What a joke.
Hallafuckalleulah. Someone bought 4500 shares at 4 pm.
Big $$$$$$ buying in now.
Sell after the 7 am PR that comes out and the stock shoots up to $123.37
Dumbass. It's up 0.28 cents.
GWPH in New York today. Big $$$$$ bout to come in.
Fo sho. Japan YEN stronger tommorrow pushing our dollar down.
NUGT gonna soar tommorrow. But better take profits.
Who sells or buys 3000 or 4000 shares everyday at 4 pm? Anyone have a clue or is it a manipulated computer shit?
Welcome to the millionaire club brother. My 1000 will only make me
$10,000,000
Yours will bring u $20,500,000.
Congrats
Gonna be spreading the word in New York Tuesday. Big $$$$$$ gonna pour in at these cheap prices. The future is here.
SubmitPrintContact
HomeAbout UsSativexR&D Investors
Media
GW Pharmaceuticals
Press Releases
Media Contacts
FAQs
Image Library
HomeMediaPress ReleasesGW Pharmaceuticals to Present at the 2016 UBS Global Healthcare Conference on 24 May
16 May 2016
London, UK, 16 May 2016: GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, “GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, today announced that Justin Gover, GW’s Chief Executive Officer, will present at the 2016 UBS Global Healthcare Conference on Tuesday, May 24, 2016, at 8:00 a.m. (EDT) at the Grand Hyatt Hotel in New York City.
A live audio webcast of the presentation will be available through GW’s corporate website in the investor relations section from the investor’s calendar of events page at www.gwpharm.com. A replay will be available soon after the live presentation.
About GW Pharmaceuticals plc
Founded in 1998, GW is a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. GW commercialized the world’s first plant-derived cannabinoid prescription drug, Sativex®, which is approved for the treatment of spasticity due to multiple sclerosis in 28 countries outside the United States. GW is advancing an orphan drug program in the field of childhood epilepsy with a focus on Epidiolex® (cannabidiol), which is in Phase 3 clinical development for the treatment of Dravet syndrome, Lennox-Gastaut syndrome and Tuberous Sclerosis Complex. GW has a deep pipeline of additional cannabinoid product candidates which includes compounds in Phase 1 and 2 trials for glioma, type 2 diabetes, schizophrenia and epilepsy. For further information, please visit www.gwpharm.com.
Enquiries:
GW Pharmaceuticals plc
(Today) +44 20 3727 1000
Stephen Schultz, VP Investor Relations (U.S.)
917 280 2424 / 401 500 6570
FTI Consulting (Media Enquiries)
Ben Atwell / Simon Conway
+ 44 20 3727 1000
FleishmanHillard (U.S. Media)
Paddi Hurley / Adam Silverstein
212 453 2382 / 917 697 9313
© GW Pharmaceuticals 2014
HomeSitemapAccessibility Disclosure & DisclaimerContactPrivacy
It's the only company to invest in.
SOARING now. It's coming y'all. Results of Phase 3 data and DEA rescheduling. Get em while they cheap. Join the millionaire club.
Bills to shut down opioids passed by speaker Ryan.
Buyout coming soon. Great woundcare prod. Used by Healogics wound centers. Huge potential. Very lucky to get in at these prices like I did.
NEWS
DEA could reclassify marijuana, allowing doctors to conduct more research
Trevor Hughes, USA TODAY
1 day ago
Facebook
Twitter
Google Plus
more
Trevor Hughes/USA TODAY
A greenhouse filled with medical marijuana growing in Denver.
DENVER — Marijuana users, researchers and investors are eager to hear whether federal officials will remove pot from the same drug classification as heroin, LSD and bath salts.
Federal drug officials say they are considering removing marijuana from what’s known as Schedule 1 classification, with a decision expected this summer.
The current classification makes it illegal to prescribe and declares that marijuana “has no currently accepted medical treatment use," although 24 states permit some form of medical marijuana use.
Reclassifying marijuana would make it easier for researchers to work with the plant, which is currently subject to strict limitations and officially can be acquired only from a single government garden. Schedule 2 drugs include morphine, methamphetamine and oxycodone.
“I think it’s just common sense to allow good science to be done,” said congressman Jared Polis, who supports the change. Polis, a Colorado Democrat, has repeatedly pushed President Obama’s administration to loosen restrictions and enforcement around cannabis use.
The Drug Enforcement Administration routinely reconsiders drug classifications, and has several times declined to change marijuana’s categorization since it was added to the list in 1970. DEA officials this week declined to discuss the rescheduling process, although agency leaders earlier this year announced they were again considering the change in a letter sent to Congress. They didn't specify a date by which they'd reach a decision.
“No one is asking to make it legal overnight. We’re saying, let’s start doing some research on it. It’s common sense,” said David Cunic, the CEO of Pazoo, which runs marijuana testing labs in California, Colorado and Washington. "People are looking for alternatives.”
Cunic, who is also a physical therapist, said he believes marijuana could serve as a safer alternative to prescription opiate painkillers. He said medical professionals are ethically obligated to empower patients with knowledge, and many doctors are concerned about the risks associated with highly addictive and potentially deadly opiates.
Not every doctor is rushing to embrace marijuana, however. Scott Krakower, an addiction disorder specialist at Zucker Hillside Hospital in Glen Oaks, N.Y., says he’s reluctant to recommend pot to his patients because there is so little research. Unlike prescription medications, marijuana comes in a wide variety of strains and strengths, and despite centuries of use, scientists don’t know exactly how it works, especially for the range of ailments its boosters say it can aid.
"Many patients are unaware that using marijuana can have devastating consequences, including higher risk of developing a mood and psychotic disorder, increased rates of other substance use and potentially dependence to the agent itself,” Krakower said in an email. "In addition, there are concerns with lack of regulation of these products and false advertising of what they contain.”
Concerns such as those raised by Krakower are precisely the reason congressman Earl Blumenauer, an Oregon Democrat, wants to see marijuana rescheduled. If doctors have concerns, he said, scientists should be allowed to answer them.
USA TODAY
Legal marijuana sales forecast to hit $23B in 4 years
“Maintaining the fiction of Schedule 1 categorization just destroys their credibility,” Blumenauer said of federal regulators.
The House of Representatives on Thursday overwhelmingly passed a Blumenauer-sponsored amendment that would allow Veterans Affairs doctors to recommend marijuana to veterans, the way a regular doctor can in 24 states. The Senate has passed a similar proposal, but the two versions must still be reconciled. The proposal doesn’t change marijuana’s classification but allows VA doctors to take advantage of existing state medical marijuana programs.
Blumenauer said the fact that both branches of Congress think veterans should have access to medical marijuana should prompt regulators to think seriously about rescheduling it.
“I think this moment is cresting,” he said. “The movement, the momentum, is palpable."
John Hudak, a senior fellow at the Brookings Institute, isn’t so sure. He said it’s unlikely the DEA and Food and Drug Administration's doctors will reschedule marijuana this year.
“Doctors are even more risk-averse than Congress is, and the DEA is staffed almost entirely by drug warriors,” he said. Hudak called on the next president to convene a summit on marijuana across America, arguing that the federal government needs to provide more clarity on the issue.
“Pretty soon it’s going to be a liability to oppose reform,” he added. "We’re not there yet, but marijuana is going in that direction.”
Back To Top
Help • Terms of Service • Privacy Notice • Your California Privacy Notice • Mobile Apps • Ad Choices • Full Site
Copyright Gannett 2016
Gonna wait for that 7 am news to pop up that's gonna make GWPH soar. Then I'm out.
Cause market is crashing already. Following same path as May 12 2008. Check it hommie.
Shooting at White House. Stocks falling.
Soaring now. 7 am next week may be to late to get in. Better buy in now and hold.
U absolutely correct. Gods gift to GWPH investors. Gonna be so filthy rich. It's only a few of us.
Gold soaring. No fed movement in June.
Derick still taking y'all's $$$$$$. Sell now.
Buy the dips.
For real Lebron. Also Google Home out to compete with Alexa. Hmmmmm
Amazon falling big. Profit taking. Interest rates going up in June. Time to sell. I'll buy them at $385.73
Sleek taking y'all's $$$$$ too.
Years of hearing him blah blah. Do the opposite of what he tells u
Derrick still taking y'all's $$$$$$. 0.8cents coming
Saudi gonna crash our markets too. $750 billion out.
Helloooooo. Dereck still taking y'all's $$$$$. Get out. Buy in at 0.7 cents.
I agree with u. We will default on our debt just as Trump has stated.
They said possible 3 times. Re listen to Bloomberg. Gonna keep going lower from here.
FEDs gonna raise rates in June. Better take profits.
It began May 12. Good luck.
Course it is. But GWPH gonna SOAR first. Sell me your shares idiot.
Oh yeah. Death Cross. !!!!!
Gonna crash y'all.
Damnnnnn. Derick still taking y'all's $$$$$$. Go see movie Money Monster. Duhhhhhhh.
Must be English teacher. Keep your day job. Amazon craahing now. Don't lose all your teacher $$$$. Hehe